In trading on Tuesday, shares of Intra-Cellular Therapies Inc (Symbol: ITCI) crossed above their 200 day moving average of $50.53, changing hands as high as $57.90 per share. Intra-Cellular Therapies Inc shares are currently trading up about 13.4% on the day. The chart below shows the one year performance of ITCI shares, versus its 200 day moving average:
Looking at the chart above, ITCI’s low point in its 52 week range is $42.01 per share, with $66 as the 52 week high point — that compares with a last trade of $54.32.
ETFs Holding APOL
RTK Price Target
BMI Stock Predictions
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
The new Income Tax Bill presented in Parliament is an exercise to make it “concise,…
Speed up Kavach This refers to the news report ‘RailTel poised for ₹ 1,000 cr…
US President Donald Trump declared a trade war by slapping 25 per cent duty on…
Stay informed with free updatesSimply sign up to the Artificial intelligence myFT Digest -- delivered…
Maharatna defence PSU Hindustan Aeronautics Limited (HAL) has signed an agreement with Collins Aerospace, an…